inHeart, a France-based developer of the world’s first AI-powered digital twin of the heart has raised $11 million in a series A funding round to commercialize its therapeutic software solutions for ablation procedures.
The startup will also use the funding to accelerate the advancements of its predictive cardiac models for cardiac illnesses such as sudden cardiac death, cardio-embolic stroke, and heart failure.
According to the company’s announcement through a press release, the latest funding round was co-led by Vesalius Biocapital IV and Elaia Partners, supported by NACO, Sofia Angel Ventures, CWR Funds, Sagana and Webit Investment Network.
In addition to the capital raised through the series A round, inHEART received crowd equity funds raised from a successful crowdfunding campaign on Tudigo and philanthropy investments from Astorg Foundation.
inHEART’s AI-driven 3D cardiac mapping could provide effective means to target and treat arrhythmias with unprecedented precision, setting a new approach in the treatment of cardiac-related illnesses.
The startup’s current AI-driven therapeutic solution aims to address the various challenges associated with conventional ablation treatment by creating highly interactive 3D models of the heart with AI-enabled cardiac CT scan or MR image segmentation.
The highly detailed 3-D heart models allow physicians to employ treatment optimization strategies based on the patient’s unique anatomy. In addition, the models help in planning for the patient’s pre-procedure planning for improved outcomes.
